References
- Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists. Am J Clin Dermatol. 2018;19(5):1–2. doi: 10.1007/s40257-018-0364-7.
- Krejci-Manwaring J, McCarty MA, Camacho F, et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol. 2006;54(5 Suppl):S235–S6. doi: 10.1016/j.jaad.2005.10.060.
- Fergus KB, Lee AW, Baradaran N, et al. Pathophysiology, clinical manifestations, and treatment of lichen sclerosus: a systematic review. Urology. 2020;135:11–19. doi: 10.1016/j.urology.2019.09.034.
- Kohn JR, Connors TM, Chan W, et al. Clinical outcomes and adherence to topical corticosteroid therapy in women with vulvar lichen sclerosus: a retrospective cohort study. J Am Acad Dermatol. 2020;83(4):1104–1109. doi: 10.1016/j.jaad.2020.05.006.
- Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10):1061–1067. doi: 10.1001/jamadermatol.2015.0643.